20 results
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
in determining independence, including the beneficial ownership of our capital stock by each non-employee director.
Board Diversity Matrix (as of March 31 … of directors.
Criteria and Diversity
In considering whether to recommend to our board of directors any specific candidate for inclusion in our board
424B3
SYRS
Syros Pharmaceuticals Inc.
8 Aug 22
Prospectus supplement
5:47pm
, if Tyme does not act responsibly in a number of key areas, including diversity and inclusion, environmental stewardship, support for local … to report their board composition and/or mandating gender diversity, including New York and California. Tyme has included consistent, transparent
S-4
0rkj7384e5 9pzhi
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
- Prev
- 1
- Next